I work with innovative companies during their most critical stages – formation, scaling and exit.
Jason Roche’s practice focuses on working with emerging technology and life science companies throughout the corporate life cycle, including on early-stage formation and structuring matters, angel and venture financings, commercial transactions, mergers and acquisitions, and general corporate governance matters.
Boston University School of Law, J.D., magna cum laude, 2017
University of Massachusetts, Amherst, B.A., magna cum laude, 2014
Bar and Court Admissions
BAR ADMISSIONS
Massachusetts
Experience
Alsym Energy, a developer of rechargeable batteries intended for applications such as stationary storage, maritime shipping and electric vehicles, in its $78 million Series C round jointly led by Tata Limited and General Catalyst, with additional funding by Thrive Capital, Thomvest and existing investor Drads Capital
ArkeaBio, a pioneer in developing technology to reduce greenhouse gas (GHG) emissions from the agricultural sector, in its $26.5 million Series A financing
Icelandic Provisions, a yogurt producer, in its $29.2 million Series C financing
Cultivate Holdings in its sale to Cresco Labs (CSE:CL) (OTCQX:CRLBF), for upfront consideration equal to $90 million plus an earnout of up to $68 million.
Venture capital firm Bessemer Venture Partners as lead investor in a $17 million funding round for money management platform Truebill
Global cannabis operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in its $69 million acquisition of Project Cannabis, a leading cannabis cultivator, wholesaler and retailer
Rental platform Zumper in a $60 million Series D round led by e.ventures, and its previous $46 million Series C financing led by Axel Springer and Stereo Capital, with participation from Blackstone and existing investors Dawn Capital, Kleiner Perkins, Breyer Capital, Scott Cook, Goodwater Capital and xfund
OnShape, creators of the first Software as a Service (SaaS) product development platform that unites robust computer aided design (CAD) with powerful data management and collaboration tools, in signing a definitive agreement to sell the business to global technology company PTC Inc. for approximately $470 million
Rammer.AI in a $1.8 million seed round
Morphic Therapeutic in its $80 million Series B financing
Inovalon Holdings Inc. (Nasdaq: INOV) in its $1.2B acquisition of ABILITY Network
Vasta Global, a provider of software solutions for clinical research and bioinformatics needs, in the sale of all of its outstanding equity to OMH-HealthEdge Holdings
Pointillist, developer of a customer journey analytics software intended to rapidly uncover customer insights and improve customer experience, in its sale to Genesys
Certica Solutions, an edtech platform-as-a-service (PaaS) company, in its acquisition of TE21
Satellite Biosciences, a developer of first-in-class, implantable satellite organs as living therapeutic solutions for serious diseases, in their $110 million Series A and Series Seed financings
AeroSafe Global, a developer of aerogels used in various transport, biomedical, pharmaceutical and other temperature sensitive products, in their Series D and Series E financings
NeoNet Capital in the $20 million Series B Financing of MarvelBiome, a biopharmaceutical company using microbes for treating diseases, led by other investors including Drads Capital
SeLux Diagnostics, a developer of a next generation phenotyping platform (NGP), in its $25 million Series B financing led by Sands Capital Ventures
Other Publications
"State, SEC Begin to Take Action Against Cryptocurrencies," Massachusetts Lawyers Weekly (March 2018)
Honors & Involvement
HONORS
Best Lawyers: Ones to Watch - Corporate Law (2026-2027) and Venture Capital Law (2026)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
